Crinetics Pharma (($CRNX)) announced an update on their ongoing clinical study. Study Overview: Crinetics Pharmaceuticals is conducting a Phase ...

Effect of Breast Cancer Radiotherapy and Cigarette Smoking on Risk of Second Primary Lung Cancer Twenty-one patients enrolled, 20 (median age, 13 years) were eligible, and 18 completed one course and ...

Pacira (($PCRX)) announced an update on their ongoing clinical study. Pacira Pharmaceuticals is conducting a study titled ‘A Multicenter, ...

Rebecca Aris interviews Dr Carlton Lee in pharmaphorum's pediatric care themed month to hear his views on the changing face of pediatric pharmacology. Dr Carlon Leee is a pediatric Clinical pharmacist ...

Expanding the evidence base for rational drug use in children presents numerous challenges, including a paucity of high-quality research on commonly used medications, complexities in designing and ...

The development of new therapeutic agents for the mitigation of pediatric disorders is largely hindered by the inability for investigators to assess pediatric pharmacokinetics (PK) in healthy patients ...

Dale L. Phelps, Robert M. Ward, Rick L. Williams, Kristi L. Watterberg, Abbot R. Laptook, Lisa A. Wrage, Tracy L. Nolen, Timothy R. Fennell, Richard A. Ehrenkranz ...

WESTLAKE VILLAGE, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) announced today that the Afrezza® safety and pharmacokinetics study in pediatric patients is now ...

MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late stage development for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' ...